Terns Pharmaceuticals (TERN) Change in Account Payables (2020 - 2023)
Historic Change in Account Payables for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to -$810000.0.
- Terns Pharmaceuticals' Change in Account Payables fell 7197.45% to -$810000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.1 million, marking a year-over-year increase of 25914.13%. This contributed to the annual value of -$367000.0 for FY2024, which is 13194.08% down from last year.
- According to the latest figures from Q4 2023, Terns Pharmaceuticals' Change in Account Payables is -$810000.0, which was down 7197.45% from -$2.2 million recorded in Q3 2023.
- Terns Pharmaceuticals' Change in Account Payables' 5-year high stood at $2.8 million during Q2 2023, with a 5-year trough of -$2.2 million in Q3 2023.
- In the last 4 years, Terns Pharmaceuticals' Change in Account Payables had a median value of -$175500.0 in 2020 and averaged $63000.0.
- Per our database at Business Quant, Terns Pharmaceuticals' Change in Account Payables skyrocketed by 158666.67% in 2021 and then tumbled by 35601.85% in 2023.
- Terns Pharmaceuticals' Change in Account Payables (Quarter) stood at $30000.0 in 2020, then soared by 1586.67% to $506000.0 in 2021, then crashed by 193.08% to -$471000.0 in 2022, then crashed by 71.97% to -$810000.0 in 2023.
- Its Change in Account Payables was -$810000.0 in Q4 2023, compared to -$2.2 million in Q3 2023 and $2.8 million in Q2 2023.